Stay updated with breaking news from Michael Albert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
28.04.2023 - EQS-News: HOMANN HOLZWERKSTOFFE GmbH / Key word(s): Annual Results/Annual Report Homann Holzwerkstoffe publishes consolidated financial statements for 2022: Strong revenue growth and clearly positive result 28.04.2023 / 09:00 CET/CEST The issuer ... Seite 1
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
GLP-1 agonists, a class of drug that's become a weight loss phenomenon and includes the likes of Wegovy, Ozempic and Mounjaro, have been touted by social media influencers as miracle medications. This hype has sparked concern among doctors and regulators who fear the drugs will be misused.
Competition to claim the weight loss market has triggered a wave of advertising that has provoked the concern of regulators and doctors worldwide. But tools for curbing the ads that go too far are limited — especially when it comes to social media.
Suzette Zuena is her own best advertisement for weight loss. Zuena, the “founder/visionary” of LH Spa & Rejuvenation in Livingston and Madison, New Jersey, has dropped 30 pounds. Her husband has lost 42 pounds. “We go out a lot,” Zuena said of the pair’s social routine. “People saw us basically shrinking.” They would ask how the couple did it. Her response: Point people to her spa and a relatively new type of medication — GLP-1 agonists, a class of drug that’s become a weight loss phenomenon. But she’s not just spreading her message in person. She’s also doing it on ...